NEWBRY logo

Newbury Pharmaceuticals AB (publ) Stock Price

OM:NEWBRY Community·SEK 82.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NEWBRY Share Price Performance

SEK 0
-2.59 (-100.00%)
SEK 0
-2.59 (-100.00%)
Price SEK 0

NEWBRY Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Newbury Pharmaceuticals AB (publ) Key Details

SEK 35.0m

Revenue

SEK 25.4m

Cost of Revenue

SEK 9.6m

Gross Profit

SEK 36.5m

Other Expenses

-SEK 26.9m

Earnings

Last Reported Earnings
May 31, 2026
Next Reporting Earnings
Oct 28, 2026
-0.89
27.47%
-76.85%
0%
View Full Analysis

About NEWBRY

Founded
2020
Employees
7
CEO
Karl Alexius Tiger Karlsson
WebsiteView website
www.newburypharma.com

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Recent NEWBRY News & Updates

Recent updates

No updates